日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BRCA1/2, PALB2 mutations and first-line CDK4/6 inhibitor efficacy in HR+ metastatic breast cancer

BRCA1/2、PALB2 突变与 HR+ 转移性乳腺癌一线 CDK4/6 抑制剂疗效

Guinel, Timothé; Lusque, Amélie; Mailliez, Audrey; Massard, Vincent; Jacot, William; Guiu, Severine; de la Motte Rouge, Thibault; Brain, Etienne; Desmoulins, Isabelle; Arnedos, Monica; Bailleux, Caroline; Goncalves, Anthony; Levy, Christelle; Bachelot, Thomas; Bosquet, Lise; Delaloge, Suzette; Frénel, Jean-Sébastien

Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy

潜在生物标志物与接受帕博利珠单抗或化疗治疗的转移性三阴性乳腺癌临床结局的关联

Cortes, Javier; Lipatov, Oleg; Im, Seock-Ah; Goncalves, Anthony; Lee, Keun Seok; Schmid, Peter; Tamura, Kenji; Testa, Laura; Ohtani, Shoichiro; Harbeck, Nadia; Loi, Sherene; Salgado, Roberto; Karantza, Vassiliki; Mejia, Jaime; Cristescu, Razvan; Loboda, Andrey; Nebozhyn, Michael; Jelinic, Petar; Huang, Lingkang; Winer, Eric P

The plasma nanoDSF denaturation profiles predict the presence of breast cancer

等离子体纳米差示扫描量热法(nanoDSF)变性曲线可预测乳腺癌的存在

Guerin, Mathilde; Eyraud, Rémi; Tsvetkov, Philippe; Finetti, Pascal; Giraudo, Alexandre; Tarpin, Carole; Hassin, Aymen; Bechlian, Didier; Mamessier, Emilie; Pakradouni, Jihane; Boher, Jean-Marie; Goncalves, Anthony; Devred, François; Bertucci, François

Efficacy of antiandrogens in androgen receptor-positive triple-negative metastatic breast cancer: Real-life data

抗雄激素治疗雄激素受体阳性三阴性转移性乳腺癌的疗效:真实世界数据

Rhanine, Yasmine; Bonnefoi, Hervé; Goncalves, Anthony; Debled, Marc; Le Moulec, Sylvestre; Bonichon, Nathalie; Macgrogan, Gaetan; Arnedos, Monica; Dubroca-Dehez, Bénédicte; Grellety, Thomas

Mutational landscape of inflammatory breast cancer

炎症性乳腺癌的突变图谱

Bertucci, François; Lerebours, Florence; Ceccarelli, Michele; Guille, Arnaud; Syed, Najeeb; Finetti, Pascal; Adélaïde, José; Van Laere, Steven; Goncalves, Anthony; Viens, Patrice; Birnbaum, Daniel; Mamessier, Emilie; Callens, Céline; Bedognetti, Davide

Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy

炎性乳腺癌的全外显子组谱及新辅助化疗的病理反应

Bertucci, François; Guille, Arnaud; Lerebours, Florence; Ceccarelli, Michele; Syed, Najeeb; Adélaïde, José; Finetti, Pascal; Ueno, Naoto T; Van Laere, Steven; Viens, Patrice; De Nonneville, Alexandre; Goncalves, Anthony; Birnbaum, Daniel; Callens, Céline; Bedognetti, Davide; Mamessier, Emilie

Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

作者更正:紫杉醇联合卡铂和度伐利尤单抗,加或不加oleclumab,用于治疗既往未接受治疗的局部晚期或转移性三阴性乳腺癌女性患者:SYNERGY I/II期随机试验

Buisseret, Laurence; Loirat, Delphine; Aftimos, Philippe; Maurer, Christian; Punie, Kevin; Debien, Véronique; Kristanto, Paulus; Eiger, Daniel; Goncalves, Anthony; Ghiringhelli, François; Taylor, Donatienne; Clatot, Florent; Van den Mooter, Tom; Ferrero, Jean-Marc; Bonnefoi, Hervé; Canon, Jean-Luc; Duhoux, Francois P; Mansi, Laura; Poncin, Renaud; Barthélémy, Philippe; Isambert, Nicolas; Denis, Zoë; Catteau, Xavier; Salgado, Roberto; Agostinetto, Elisa; de Azambuja, Evandro; Rothé, Françoise; Craciun, Ligia; Venet, David; Romano, Emanuela; Stagg, John; Paesmans, Marianne; Larsimont, Denis; Sotiriou, Christos; Ignatiadis, Michail; Piccart-Gebhart, Martine

Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

紫杉醇联合卡铂和度伐利尤单抗,加或不加oleclumab,用于治疗既往未接受治疗的局部晚期或转移性三阴性乳腺癌女性患者:一项随机SYNERGY I/II期试验

Buisseret, Laurence; Loirat, Delphine; Aftimos, Philippe; Maurer, Christian; Punie, Kevin; Debien, Véronique; Kristanto, Paulus; Eiger, Daniel; Goncalves, Anthony; Ghiringhelli, François; Taylor, Donatienne; Clatot, Florent; Van den Mooter, Tom; Ferrero, Jean-Marc; Bonnefoi, Hervé; Canon, Jean-Luc; Duhoux, Francois P; Mansi, Laura; Poncin, Renaud; Barthélémy, Philippe; Isambert, Nicolas; Denis, Zoë; Catteau, Xavier; Salgado, Roberto; Agostinetto, Elisa; de Azambuja, Evandro; Rothé, Françoise; Craciun, Ligia; Venet, David; Romano, Emanuela; Stagg, John; Paesmans, Marianne; Larsimont, Denis; Sotiriou, Christos; Ignatiadis, Michail; Piccart-Gebhart, Martine

Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database

大型多中心真实世界数据库中转移性乳腺癌患者的生存结局与生殖系BRCA1/2状态的关系

Mailliez, Audrey; D'Hondt, Veronique; Lusque, Amelie; Caron, Olivier; Cabel, Luc; Goncalves, Anthony; Debled, Marc; Gladieff, Laurence; Ferrero, Jean-Marc; Petit, Thierry; Mouret-Reynier, Marie Ange; Eymard, Jean-Christophe; Levy, Christelle; Uwer, Lionel; Leheurteur, Marianne; Desmoulins, Isabelle; Bachelot, Thomas; Frenel, Jean-Sebastien; de la Motte Rouge, Thibault; Simon, Gaëtane; Jacot, William; Delaloge, Suzette

Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study

一项多中心全国真实世界观察性研究:依维莫司治疗晚期激素受体阳性乳腺癌的长期疗效

François-Martin, Hélène; Lardy-Cléaud, Audrey; Pistilli, Barbara; Levy, Christelle; Diéras, Véronique; Frenel, Jean-Sébastien; Guiu, Séverine; Mouret-Reynier, Marie-Ange; Mailliez, Audrey; Eymard, Jean-Christophe; Petit, Thierry; Ung, Mony; Desmoulins, Isabelle; Augereau, Paule; Bachelot, Thomas; Uwer, Lionel; Debled, Marc; Ferrero, Jean-Marc; Clatot, Florian; Goncalves, Anthony; Chevrot, Michael; Chabaud, Sylvie; Cottu, Paul